Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

708 recalls · Class II, newest first

Class II · Moderate risk

Phentermine 15mg grey/Yellow Capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 11534-0157-03 D-1525-2020
Class II · Moderate risk

Phentermine HCL Gray/Yellow capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 10702-0026-10 D-1524-2020
Class II · Moderate risk

Phendimetrazine Brown/Clear Capsules

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 69543-0409-11 D-1523-2020
Class II · Moderate risk

Phendimetrazine Yellow Tabs 35mg

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 69543-0410-11 D-1522-2020
Class II · Moderate risk

Phendimetrazine Yellow Tabs 35mg

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 0702-0077-10 D-1521-2020
Class II · Moderate risk

Topiramate 25mg Tabs White/round tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 47335-0707-13 D-1520-2020
Class II · Moderate risk

Thyroid Neutral Tabs 2 gr

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 64727-3308-02 D-1519-2020
Class II · Moderate risk

Thyroid 1 Gr tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 64727-3300-01 D-1518-2020
Class II · Moderate risk

Thyroid 1 Grain Tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 64727-3300-02 D-1517-2020
Class II · Moderate risk

Hydrochlorothiazide 50mg tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 16729-0184-17 D-1516-2020
Class II · Moderate risk

Hydrochlorothiazide

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 29300-0128-10 D-1515-2020
Class II · Moderate risk

Hydrochlorothiazide 25mg tablets

CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Terminated cGMP deviation Calvin Scott & Company, Inc. NDC 16729-0183-17 D-1514-2020
Class II · Moderate risk

Vilamit Mb

cGMP deviations

Terminated cGMP deviation Vilvet Pharmaceuticals Inc. NDC 71186-002-35 D-1487-2020
Class II · Moderate risk

LUX EOI Hand Sanitizing Gel

CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Terminated Chemical / undeclared Real Clean Distribuciones SA de CV NDC 74882-007-02 D-1582-2020
Class II · Moderate risk

Born Basic.

CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Terminated Chemical / undeclared Real Clean Distribuciones SA de CV D-1581-2020
Class II · Moderate risk

scent theory KEEP CLEAN Moisturizing Hand Sanitizer

CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Terminated Chemical / undeclared Real Clean Distribuciones SA de CV D-1580-2020
Class II · Moderate risk

scent theory KEEP IT CLEAN

CGMP Deviations: Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.

Terminated Chemical / undeclared Real Clean Distribuciones SA de CV D-1579-2020
Class II · Moderate risk

Mibelas 24 Fe

Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test.

Terminated Impurity / degradation Lupin Pharmaceuticals Inc. D-1502-2020
Class II · Moderate risk

Lisinopril Tablets USP

Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68001-334-08 D-1413-2020
Class II · Moderate risk

Lidocaine Patch 5%

Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 0591-3525-30 D-1492-2020

Recalls by year